CoChat

Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis

Choong, Peter F.M., Nadesapillai, Anne P.W. · 2003 · Clinical Orthopaedics and Related Research
Cited by 145

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The urokinase plasminogen activator (uPA) system is central to a spectrum of biologic processes including fibrinoloysis, inflammation, atherosclerotic plaque formation, matrix remodeling during wound healing, tumor invasion, angiogenesis, and metastasis. Binding of uPA with its receptor (uPAR) initiates a proteolytic cascade that results in the conversion of plasminogen to plasmin. Plasmin through its own proteolytic function degrades a range of extracellular basement membrane components and activates others such as the metalloproteinases. Independent of catalytic activity, uPAR also is involved in cell signaling, interactions with integrins, cell motility, adhesion and invasion, and angiogenesis. Over expression of uPA or uPAR is a feature of malignancy and is correlated with tumor progression and metastasis. In contrast, inhibition of expression of these components leads to a reduction in the invasive and metastatic capacity of many tumors. Strategies that target uPA or its receptor with the aim of disrupting the interaction between the two or the ligand independent actions of uPAR include antisense technology, monoclonal antibodies, cytotoxic antibiotics, and synthetic inhibitors of uPA. Targeted therapy is a goal of future cancer treatment and the uPA system is a likely candidate for manipulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.blo0000093845.72468.bd

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 101

  1. Aguirre Ghiso, 1999, J Cell Biol, 147, 89, 10.1083/jcb.147.1.89 · DOI · Paper page
  2. Andreasen, 1990, Mol Cell Endocrinol, 68, 1, 10.1016/0303-7207(90)90164-4 · DOI · Paper page
  3. Blasi, 1999, Thromb Haemost, 82, 298, 10.1055/s-0037-1615846 · DOI · Paper page
  4. Bohuslav, 1995, J Exp Med, 181, 1381, 10.1084/jem.181.4.1381 · DOI · Paper page
  5. Bugge, 1995, J Biol Chem, 270, 16886, 10.1074/jbc.270.28.16886 · DOI · Paper page
  6. Buo, 1995, Hum Pathol, 26, 1133, 10.1016/0046-8177(95)90276-7 · DOI
  7. Burgle, 1997, Biol Chem, 378, 231, 10.1515/bchm.1997.378.3-4.231 · DOI · Paper page
  8. Carmeliet, 1994, Nature, 368, 419, 10.1038/368419a0 · DOI · Paper page
  9. Chakraborty, 2002, Can J Physiol Pharmacol, 80, 116, 10.1139/y02-016 · DOI · Paper page
  10. Chandrasekar, 2003, Oncogene, 22, 392, 10.1038/sj.onc.1206164 · DOI
  11. Chapman, 1997, Curr Opin Cell Biol, 9, 714, 10.1016/S0955-0674(97)80126-3 · DOI · Paper page
  12. Chavakis, 1998, Blood, 91, 2305, 10.1182/blood.V91.7.2305 · DOI
  13. Chiaradonna, 1999, EMBO J, 18, 3013, 10.1093/emboj/18.11.3013 · DOI
  14. Choong, 1996, Int J Cancer, 69, 268, 10.1002/(SICI)1097-0215(19960822)69:4<268::AID-IJC5>3.0.CO;2-V · DOI
  15. Colman, 1997, J Clin Invest, 100, 1481, 10.1172/JCI119669 · DOI · Paper page
  16. Conese, 1995, J Cell Biol, 131, 1609, 10.1083/jcb.131.6.1609 · DOI · Paper page
  17. Crowley, 1993, Proc Natl Acad Sci U S A, 90, 5021, 10.1073/pnas.90.11.5021 · DOI · Paper page
  18. Cubellis, 1990, EMBO J, 9, 1079, 10.1002/j.1460-2075.1990.tb08213.x · DOI · Paper page
  19. Dano, 1985, Adv Cancer Res, 44, 139, 10.1016/S0065-230X(08)60028-7 · DOI · Paper page
  20. Degryse, 1999, Blood, 94, 649, 10.1182/blood.V94.2.649 · DOI · Paper page
  21. Deng, 1996, J Cell Biol, 134, 1563, 10.1083/jcb.134.6.1563 · DOI · Paper page
  22. Dewerchin, 1996, J Clin Invest, 97, 870, 10.1172/JCI118489 · DOI · Paper page
  23. Duffy, 1988, Cancer, 62, 531, 10.1002/1097-0142(19880801)62:3<531::AID-CNCR2820620315>3.0.CO;2-B · DOI · Paper page
  24. Duffy, 1988, Cancer Res, 48, 1348
  25. Fisher, 2000, Breast Cancer Res Treat, 61, 1, 10.1023/A:1006445129195 · doi:10.1023/a:1006445129195
  26. Fisher, 2001, Clin Cancer Res, 7, 1654
  27. Foekens, 1992, Cancer Res, 52, 6101
  28. Galimi, 2001, J Immunol, 166, 1241, 10.4049/jimmunol.166.2.1241 · DOI · Paper page
  29. Gleeson, 1993, Cancer, 72, 1670, 10.1002/1097-0142(19930901)72:5<1670::AID-CNCR2820720529>3.0.CO;2-# · doi:10.1002/1097-0142(19930901)72:5<1670::aid-cncr2820720529>3.0.co;2-#
  30. Goretzki, 1992, FEBS Lett, 297, 112, 10.1016/0014-5793(92)80339-I · DOI · Paper page
  31. Grondahl-Hansen, 1993, Cancer Res, 53, 2513
  32. Guo, 2000, FASEB J, 14, 1400, 10.1096/fasebj.14.10.1400 · doi:10.1096/fasebj.14.10.1400
  33. Hahn-Dantona, 1999, Ann N Y Acad Sci, 878, 372, 10.1111/j.1749-6632.1999.tb07696.x · DOI
  34. Hasui, 1996, Urology, 47, 34, 10.1016/S0090-4295(99)80378-1 · DOI
  35. Heiss, 1995, Nat Med, 1, 1035, 10.1038/nm1095-1035 · DOI · Paper page
  36. Higazi, 1996, Blood, 87, 3545, 10.1182/blood.V87.9.3545.bloodjournal8793545 · doi:10.1182/blood.v87.9.3545.bloodjournal8793545
  37. Hildenbrand, 1995, Br J Cancer, 72, 818, 10.1038/bjc.1995.419 · DOI · Paper page
  38. Hildenbrand, 1995, Pathol Res Pract, 191, 403, 10.1016/S0344-0338(11)80726-0 · doi:10.1016/s0344-0338(11)80726-0
  39. Hildenbrand, 1999, J Leukoc Biol, 66, 40, 10.1002/jlb.66.1.40 · DOI
  40. Hofmann, 1996, J Urol, 155, 858, 10.1016/S0022-5347(01)66328-6 · doi:10.1016/s0022-5347(01)66328-6
  41. Hoyer-Hansen, 1997, FEBS Lett, 420, 79, 10.1016/S0014-5793(97)01491-9 · DOI
  42. Hsu, 1995, Am J Pathol, 147, 114
  43. Janicke, 1989, Lancet, 2, 1049, 10.1016/S0140-6736(89)91070-2 · DOI
  44. Jean, 2001, Crit Rev Immunol, 21, 275, 10.1615/CritRevImmunol.v21.i1-3.180 · DOI
  45. Jorg, 1985, Thromb Res, 39, 323, 10.1016/0049-3848(85)90228-2 · doi:10.1016/0049-3848(85)90228-2
  46. Kanse, 1996, Exp Cell Res, 224, 344, 10.1006/excr.1996.0144 · doi:10.1006/excr.1996.0144
  47. Keyt, 1996, J Biol Chem, 271, 7788, 10.1074/jbc.271.13.7788 · DOI · Paper page
  48. Kirchheimer, 1989, Eur J Biochem, 181, 103, 10.1111/j.1432-1033.1989.tb14699.x · doi:10.1111/j.1432-1033.1989.tb14699.x
  49. Kobayashi, 1994, Cancer Res, 54, 6539
  50. Kobayashi, 1994, Int J Cancer, 57, 727, 10.1002/ijc.2910570520 · DOI · Paper page
  51. Kobayashi, 1994, Thromb Haemost, 71, 474, 10.1055/s-0038-1642463 · DOI
  52. Kobayashi, 1991, J Biol Chem, 266, 5147, 10.1016/S0021-9258(19)67767-7 · DOI · Paper page
  53. Koshelnick, 1997, J Biol Chem, 272, 28563, 10.1074/jbc.272.45.28563 · DOI · Paper page
  54. Kuhn, 1994, Gynecol Oncol, 55, 401, 10.1006/gyno.1994.1313 · DOI
  55. Landis, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 · DOI · Paper page
  56. Lansink, 1998, Blood, 92, 927, 10.1182/blood.V92.3.927 · DOI
  57. Li, 1998, Gene Ther, 5, 1105, 10.1038/sj.gt.3300742 · DOI · Paper page
  58. Lijnen, 1994, Eur J Biochem, 224, 567, 10.1111/j.1432-1033.1994.00567.x · doi:10.1111/j.1432-1033.1994.00567.x
  59. Luparello, 2003, J Cell Sci, 116, 2421, 10.1242/jcs.00472 · DOI
  60. Mahabeleshwar, 2003, J Biol Chem, 278, 6209, 10.1074/jbc.M208905200 · DOI
  61. Marchina, 1996, Int J Biochem Cell Biol, 28, 1141, 10.1016/1357-2725(96)00055-6 · doi:10.1016/1357-2725(96)00055-6
  62. Mignatti, 1996, Enzyme Protein, 49, 117, 10.1159/000468621 · DOI · Paper page
  63. Miles, 1988, Blood, 72, 628, 10.1182/blood.V72.2.628.628 · DOI
  64. Mohan, 1999, Cancer Res, 59, 3369
  65. Mondino, 1999, Thromb Haemost, 82, 19
  66. Mukhina, 2000, J Biol Chem, 275, 16450, 10.1074/jbc.M909080199 · DOI
  67. Murphy, 1999, APMIS, 107, 38, 10.1111/j.1699-0463.1999.tb01524.x · DOI · Paper page
  68. Naldini, 1995, J Biol Chem, 270, 603, 10.1074/jbc.270.2.603 · DOI · Paper page
  69. Nekarda, 1994, Cancer Res, 54, 2900
  70. Nguyen, 1999, J Cell Biol, 146, 149, 10.1083/jcb.146.1.149 · DOI · Paper page
  71. Nguyen, 2000, J Biol Chem, 275, 19382, 10.1074/jbc.M909575199 · DOI · Paper page
  72. Nielsen, 1988, J Biol Chem, 263, 2358, 10.1016/S0021-9258(18)69214-2 · DOI · Paper page
  73. Nykjaer, 1997, EMBO J, 16, 2610, 10.1093/emboj/16.10.2610 · DOI · Paper page
  74. Ohtani, 1995, Int J Cancer, 62, 691, 10.1002/ijc.2910620608 · doi:10.1002/ijc.2910620608
  75. Park, 1993, Mol Biol Cell, 4, 1317, 10.1091/mbc.4.12.1317 · DOI · Paper page
  76. Pedersen, 1994, Cancer Res, 54, 4671
  77. Pedersen, 1994, Cancer Res, 54, 120
  78. Petersen, 1988, J Biol Chem, 263, 11189, 10.1016/S0021-9258(18)37940-7 · DOI · Paper page
  79. Ploug, 1991, Semin Thromb Hemost, 17, 183, 10.1055/s-2007-1002608 · DOI
  80. Ploug, 1991, J Biol Chem, 266, 1926, 10.1016/S0021-9258(18)52382-6 · DOI · Paper page
  81. Proescholdt, 1999, J Neuropathol Exp Neurol, 58, 613, 10.1097/00005072-199906000-00006 · DOI · Paper page
  82. Remacle-Bonnet, 1997, Int J Cancer, 72, 835, 10.1002/(SICI)1097-0215(19970904)72:5<835::AID-IJC21>3.0.CO;2-6 · DOI
  83. Resnati, 1996, EMBO J, 15, 1572, 10.1002/j.1460-2075.1996.tb00502.x · DOI · Paper page
  84. Rettenberger, 1995, Biol Chem Hoppe Seyler, 376, 587, 10.1515/bchm3.1995.376.10.587 · doi:10.1515/bchm3.1995.376.10.587
  85. Ribatti, 1999, J Cell Sci, 112, 4213, 10.1242/jcs.112.23.4213 · DOI
  86. Schmitt, 1991, Biomed Biochim Acta, 50, 731
  87. Schmitt, 1997, Thromb Haemost, 78, 285, 10.1055/s-0038-1657541 · DOI
  88. Schmitt, 1997, Br J Cancer, 76, 306, 10.1038/bjc.1997.383 · DOI
  89. Stack, 1994, J Biol Chem, 269, 9416, 10.1016/S0021-9258(17)36896-5 · DOI · Paper page
  90. Stahl, 1995, J Cell Biol, 129, 335, 10.1083/jcb.129.2.335 · DOI · Paper page
  91. Tatsuta, 1997, Int J Oncol, 10, 125
  92. Van Veldhuizen, 1996, Am J Med Sci, 312, 8, 10.1097/00000441-199607000-00002 · doi:10.1097/00000441-199607000-00002
  93. Wary, 1998, Cell, 94, 625, 10.1016/S0092-8674(00)81604-9 · DOI · Paper page
  94. Webb, 2000, Cancer Res, 60, 342
  95. Webb, 2000, J Cell Sci, 113, 123, 10.1242/jcs.113.1.123 · DOI · Paper page
  96. Wei, 1994, J Biol Chem, 269, 32380, 10.1016/S0021-9258(18)31646-6 · DOI · Paper page
  97. Wei, 1999, J Cell Biol, 144, 1285, 10.1083/jcb.144.6.1285 · DOI · Paper page
  98. Whitesell, 1992, Cancer Res, 52, 1721
  99. Xu, 1997, Hum Pathol, 28, 206, 10.1016/S0046-8177(97)90108-8 · DOI
  100. Yebra, 1996, J Biol Chem, 271, 29393, 10.1074/jbc.271.46.29393 · DOI · Paper page
  101. Zanetti, 1998, J Pathol, 186, 287, 10.1002/(SICI)1096-9896(199811)186:3<287::AID-PATH175>3.0.CO;2-X · doi:10.1002/(sici)1096-9896(199811)186:3<287::aid-path175>3.0.co;2-x

Cited by

See all 145

Metadata

Authors
Choong, P. F. M., & Nadesapillai, A. P. W.
Venue
Clinical Orthopaedics and Related Research
Published
2003-10
Volume
415
Pages
S46-S58
ISSN
0009-921X (ISSN-L)
OpenAlex
W4231451806
Cited by
145
References
1
FWCI
3.58
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis. https://app.cochat.ai/papers/10.1097/01.blo0000093845.72468.bd
The paper
Choong, P. F. M., & Nadesapillai, A. P. W. (2003). Urokinase Plasminogen Activator System: A Multifunctional Role in Tumor Progression and Metastasis. Clinical Orthopaedics and Related Research. https://doi.org/10.1097/01.blo0000093845.72468.bd

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.